Publicacións en colaboración con investigadores/as de Instituto Cajal (9)

2019

  1. The role of clonal communication and heterogeneity in breast cancer

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. Aging-related dysregulation in enteric dopamine and angiotensin system interactions: Implications for gastrointestinal dysfunction in the elderly

    Oncotarget, Vol. 9, Núm. 13, pp. 10834-10846

  2. Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Coordination of m6A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming

    Cell Stem Cell, Vol. 17, Núm. 6, pp. 689-704

2014

  1. Aging-related dysregulation of dopamine and angiotensin receptor interaction

    Neurobiology of Aging, Vol. 35, Núm. 7, pp. 1726-1738

2011

  1. Guía de recomendaciones en la aplicación de modelos animales para el estudio del ictus

    Neurologia, Vol. 26, Núm. 2, pp. 105-110

1995

  1. Butyrophenone analogues: Synthesis of 2-methyl-3-ethyl-5-aminoethyl-4,5,6,7-tetrahydroindol-4-ones, and their affinities for d 1 , d 2 and 5-ht 2a receptors

    Bioorganic and Medicinal Chemistry Letters, Vol. 5, Núm. 6, pp. 579-584

1994

  1. Pyridazine derivatives XII. Synthesis and antipsychotic-antidepressant activity of some butyrophenone derivatives of 6-phenylpyridazine

    European Journal of Medicinal Chemistry, Vol. 29, Núm. 11, pp. 831-839

1991

  1. 5-HT2 antagonist activity of 3-aminomethyltetralones

    Bioorganic and Medicinal Chemistry Letters, Vol. 1, Núm. 12, pp. 717-720